Skip to main content

$0.049 0.007 (16.67%)

High

$0.05

Low

$0.04

Trades

74

Turnover

$48,318

Volume

1,094,468
30 June 2023 at 4:10pm
Register to track PXS and receive email alerts.
Subject
PXS Ann: Application for quotation of securities - PXS

PXS Ann: Change of Director's Interest Notice

PXS Ann: Application for quotation of securities - PXS

PXS Ann: Change of Director's Interest Notice

PXS Ann: Application for quotation of securities - PXS

PXS Ann: Quarterly Activities Report

PXS Ann: Quarterly Activities/Appendix 4C Cash Flow Report

PXS Ann: Becoming a substantial holder

PXS Ann: Corporate Governance Statement

PXS Ann: Appendix 4G

PXS Ann: Annual Report to shareholders

PXS Ann: Notice of Annual General Meeting/Proxy Form

PXS Ann: Change in substantial holding

PXS Ann: Becoming a substantial holder

PXS Ann: Section 708A(5)(e) Notice

PXS Ann: Application for quotation of securities - PXS

PXS Ann: Proposed issue of securities - PXS

PXS Ann: Proposed issue of securities - PXS

PXS Ann: PXS announces positive interim data from myelofibrosis trial

PXS Ann: Investor Presentation

PXS Ann: Placement

PXS Ann: Trading Halt

PXS Ann: Proposed Issue of Securities to Chief Executive Officer

PXS Ann: Notification regarding unquoted securities - PXS

PXS Ann: Investor Presentation Interim Data from Skin Scarring Study

PXS Ann: PXS Releases Promising Interim Data from Skin Scarring Study

PXS Ann: Date of Virtual AGM and Date for Director Nominations

PXS Ann: Investor presentation

PXS Ann: Application for quotation of securities - PXS

PXS Ann: PXS to Receive Stg2.9m from Parkinsons UK for New Trial

PXS Ann: Preliminary Final Report

PXS Ann: Change of Director's Interest Notice

PXS Ann: Notification of cessation of securities - PXS

PXS Ann: Notification of cessation of securities - PXS

PXS Ann: Pharmaxis Receives Aptar Option Exercise Fees of US$5m

PXS Ann: Final Director's Interest Notice

PXS Ann: Director Appointment/Resignation

PXS Ann: Aptar Pharma Pays PXS Us$5m to Acquire Orbital Technology

PXS Ann: Investor presentation for quarterly shareholder update

PXS Ann: Investor presentation

PXS Ann: Quarterly Activities/Appendix 4C Cash Flow Report

PXS Ann: Quarterly Appendix 4C Cash Flow Report

PXS Ann: Pharmaxis Quarterly Shareholder Update and Investor Briefing

PXS Ann: Results of Meeting

PXS Ann: Notification regarding unquoted securities - PXS

PXS Ann: Appointment of Dr Jana Baskar as Chief Medical Officer

PXS Ann: Application for quotation of securities - PXS

PXS Ann: Notice of General Meeting/Proxy Form

PXS Ann: Application for quotation of securities - PXS

PXS Ann: Application for quotation of securities - PXS

Register to track PXS and receive email alerts.

Similar Companies

CAN
CPH
EOF
IHL
MVP
MYX
NEU
PBP
RCE
SPL